• Publication
  • October 16, 2003: Lois Swirsky Gold and Thomas H. Slone. Letter to the Editor: Aristolochic Acid, an Herbal Carcinogen, Sold on the Web after FDA Alert. New England Journal of Medicine (volume 349, pp. 1576-1577)
• Letters to the U.S. Food and Drug Administration (FDA)
  
  Note: The tables below are from March 2003, and product ingredient lists may have changed since that time.
  
  
  • March 4, 2003: Lois Swirsky Gold and Thomas H. Slone
    • Letter to the FDA about Hazardous Products on the Web that List Ingredients Known or Suspected to Contain Aristolochic Acid.
      • Table 1. Herbal Products Available on the Web that List Ingredients Known to Contain Aristolochic Acid from March 4, 2003 letter to FDA
      • Table 2. Herbal Products Available on the Web that List Ingredients That May Be Adulterated With Aristolochic Acid from March 4, 2003 letter to FDA
      • Table 3. Herbal Products Available on the Web that Have No Latin Name But Are Likely To Be Asarum spp. that Contain Aristolochic Acid from March 4, 2003 letter to FDA
  • June 24, 2003: Lois Swirsky Gold. Letter to the FDA about Hazardous Products on the Web Known or Suspected to Contain Aristolochic Acid.
• Methods used to search the Web for products potentially containing Aristolochic Acid
• FDA action on Aristolochic Acid (2000-2001)
• Update in 2007 of FDA action
  
  
• Carcinogenic Potency Database Analysis of Animal Cancer Tests on Aristolochic Acid
  • 
    
  • Methods used to develop the CPDB, describing sources of data, inclusion criteria, choice of tissue and tumor to include, etc.
  • A guide describes each field in the screen version of the CPDB.

Return to the Carcinogenic Potency Database Project (CPDB) Home Page:

Last updated: August 6, 2007